Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.68
-0.18 (-3.07%)
At close: May 12, 2026, 4:00 PM EDT
5.80
+0.12 (2.11%)
After-hours: May 12, 2026, 6:48 PM EDT
Abeona Therapeutics Revenue
In the year 2025, Abeona Therapeutics had annual revenue of $5.82M. Abeona Therapeutics had revenue of $3.00M in the quarter ending December 31, 2025.
Revenue (ttm)
$5.82M
Revenue Growth
n/a
P/S Ratio
55.51
Revenue / Employee
$25,752
Employees
226
Market Cap
323.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.82M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 3.50M | 2.09M | 147.52% |
| Dec 31, 2022 | 1.41M | -1.59M | -52.87% |
| Dec 31, 2021 | 3.00M | -7.00M | -70.00% |
| Dec 31, 2020 | 10.00M | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 3.00M | 2.16M | 258.18% |
| Dec 31, 2017 | 837.00K | -52.00K | -5.85% |
| Dec 31, 2016 | 889.00K | -151.00K | -14.52% |
| Dec 31, 2015 | 1.04M | 115.00K | 12.43% |
| Dec 31, 2014 | 925.00K | -1.12M | -54.70% |
| Dec 31, 2013 | 2.04M | -2.36M | -53.63% |
| Dec 31, 2012 | 4.40M | 2.57M | 139.48% |
| Dec 31, 2011 | 1.84M | 1.36M | 282.33% |
| Dec 31, 2010 | 481.00K | 129.00K | 36.65% |
| Dec 31, 2009 | 352.00K | 61.00K | 20.96% |
| Dec 31, 2008 | 291.00K | 234.00K | 410.53% |
| Dec 31, 2007 | 57.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Niagen Bioscience | 130.42M |
| Bicycle Therapeutics | 63.50M |
| Lineage Cell Therapeutics | 14.56M |
| Surrozen | 7.49M |
| Compass Therapeutics | 850.00K |
ABEO News
- 1 day ago - Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN® - GlobeNewsWire
- 8 days ago - Abeona Therapeutics® Announces Date of First Quarter Financial Results - GlobeNewsWire
- 11 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York - GlobeNewsWire
- 2 months ago - Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global - TheFly
- 2 months ago - Abeona Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Options Volatility and Implied Earnings Moves Today, March 17, 2026 - TipRanks